BioCentury | Feb 21, 2018
Distillery Therapeutics

Cancer

...expression. Next steps include testing an anti-NCR2 mAb. TARGET/MARKER/PATHWAY: Natural cytotoxicity triggering receptor (NCR2; NKp44); platelet derived growth factor DD...
...Mo. email: mcolonna@wustl.edu Winnie Pong Washington University School of Medicine in St. Louis Natural cytotoxicity triggering receptor (NCR2) (NKp44) Platelet derived growth factor DD...
Items per page:
1 - 1 of 1